Thrilled to share our latest @pnas.org paper: antibodies that prevent malaria, discovered from a child with prior exposure.
Using our REpAb® platform, we sequenced antibodies that block a key parasite–blood vessel interaction central to severe malaria.
www.pnas.org/doi/10.1073/...
Posts by Rapid Novor, Inc.
Thanks to the ASH for discussing a new flavor of anti-PF4 antibodies! This antibody we published on recently in the NEJM is neither HIT-like or VITT-like. Many thanks to @rapidnovor.bsky.social for their expertise! Here is the feature in the Hematologist:
ashpublications.org/thehematolog...
Spring conference season is in full swing, and we’re getting ready for ASMS 2025 in Baltimore from June 1–5!
Beyond the 3 posters, we are soft launching our REpAb anti-idiotype antibody discovery service.
Visit our booth 229 and learn how you can 'discover smart'?
#ASMS2025
Exciting news! Our latest research is now published in @naturecomms.bsky.social: “De Novo Protein Sequencing of Antibodies for Identification of Neutralizing Antibodies in Human Plasma Post SARS-CoV-2 Vaccination.”
Check out the paper here: hubs.ly/Q02V9wHv0
#AntibodyDiscovery
Get inspired by others. Meet Evosep One users from MRM Proteomics Inc. and Rapid Novor at our #USHUPO2025 breakfast seminar and enjoy your morning coffee while learning about fully automated and standardized #LCMS workflows for #proteomics.
Meet our speakers and save your seat at our website.